Australia TGA ARTG recordMedicine chamber spacer
Australia TGA ARTG Registered Device · GlaxoSmithKline Australia Pty Ltd · GlaxoSmithKline Trading Services Limited · Class IIb · Started October 25, 2022
Good Name: GlaxoSmithKline Australia Pty Ltd - Medicine chamber spacer
- Risk Class
- Class IIb
- Product Type
- Procedure Pack
- ARTG Category
- General
- Start Date
- October 25, 2022
- Effective Date
- October 25, 2022
- Country
- Ireland
- Address
- 12 Riverwalk Citywest Business Campus, Dublin 24, D24 YK11
The Volumatic Spacer Device is a breath activated holding device designed to enable the use of the pressurised metered dose inhaler by a patient. A chamber for use with Seretide, Ventolin and Flixotide metered dose aerosol inhalers, designed to hold the spray before it is breathed in.
Access comprehensive regulatory information for Medicine chamber spacer in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is sponsored by GlaxoSmithKline Australia Pty Ltd, manufactured by GlaxoSmithKline Trading Services Limited in Ireland. The device registration started on October 25, 2022.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.